Abstract
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure was developed to aid clinicians with a dimensional assessment of psychopathology; however, this measure resembles a screening tool for several symptomatic domains. The objective of the current study was to examine the basic parameters of sensitivity, specificity, positive and negative predictive power of the measure as a screening tool. One hundred and fifty patients in a correctional community center filled out the measure prior to a psychiatric evaluation, including the Mini International Neuropsychiatric Interview screen. The above parameters were calculated for the domains of depression, mania, anxiety, and psychosis. The results showed that the sensitivity and positive predictive power of the studied domains was poor because of a high rate of false positive answers on the measure. However, when the lowest threshold on the Cross-Cutting Symptom Measure was used, the sensitivity of the anxiety and psychosis domains and the negative predictive values for mania, anxiety and psychosis were good. In conclusion, while it is foreseeable that some clinicians may use the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a screening tool, it should not be relied on to identify positive findings. It functioned well in the negative prediction of mania, anxiety and psychosis symptoms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Narrow W, Clarke D, Kuramoto J. DSM-5 Field Trials in the United States and Canada, Part III: Development and Reliability Testing of a Cross-Cutting Symptom Assessment for DSM-5. Am J Psychiatry. 2013; 170: 71–82
Clarke D, Kuhl E. DSM-5 cross-cutting symptom measures: a step towards the future of psychiatric care? World Psychiatry. 2014; 13: 214–216
Whooley M. Screening for Depression—A Tale of Two Questions. JAMA Internal Medicine Published online January 26, 2016
Jones D. Dimensional and Cross-Cutting Assessment in the DSM-5. J. Counseling & Development. 2012; 90: 481–487
Martin M, Colman I, Simpson A. Mental health screening tools in correctional institutions: A systematic review. BMC Psychiatry. 2013; 13: 275–281
Steadman H, Osher F, Clark Robbins P. Prevalence of Serious Mental Illness Among Jail Inmates. Psychiatric Services. 2009; 60:761–765
Bastiaens L. Poor Practice, Managed Care, and Magic Pills: Have We Created a Mental Health Monster? Psychiatric Times. April 29, 2011
Bastiaens L, Galus J, Goodlin M. The 12 item W.H.O.D.A.S. as primary self report outcome measure in a correctional community treatment center for dually diagnosed patients. Psychiatr Q. 2015; 86: 219–224
Brooker C, Repper J, Sirdifield C. Review of service delivery and organisational research focused on prisoners with mental disorders. J Forens Psychiatry Psychol. 2009; 20: S102-S123
Whooley M, Avins A, Miranda J. Case-finding instruments for depression: two questions are as good as many. J Gen Intern Med. 1997; 12: 439–445
Zimmerman M, Mattia J. A Self-Report Scale to Help Make Psychiatric Diagnoses: The Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry. 2001; 58: 787–794
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Bastiaens, L., Galus, J. The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a Screening Tool. Psychiatr Q 89, 111–115 (2018). https://doi.org/10.1007/s11126-017-9518-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11126-017-9518-7